Apriem Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Apriem Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,750	Closed	-$277K	–	132
2018 Q3	$277K	Buy	1,750 +1,000	+133%	+$151K	0.06%	113
2018 Q2	$105K	Sell	750 -2,500	-77%	-$343K	0.02%	168
2018 Q1	$432K	Buy	+3,250	New	+$444K	0.11%	76
2017 Q2	–	Sell	-300	Closed	-$32K	–	267
2017 Q1	$32K	Hold	300	–	–	0.01%	282
2016 Q4	$27K	Sell	300 -1,125	-79%	-$105K	0.01%	302
2016 Q3	$142K	Buy	1,425 +300	+27%	+$29.4K	0.04%	135
2016 Q2	$101K	Buy	+1,125	New	+$103K	0.03%	163
2014 Q3	–	Sell	-1,130	Closed	-$93K	–	545
2014 Q2	$93K	Buy	+1,130	New	+$86.4K	0.04%	152

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Apriem Advisors's FBT Position: Q4 2018 in Review

Apriem Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 1,750 shares — an estimated $277K sold.

Apriem Advisors first reported a position in FBT in Q2 2014 and held it in 8 quarters. The position peaked at $432K in Q1 2018. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

Apriem Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
Apriem Advisors sold 1,750 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $277K.
Apriem Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and held it in 8 quarters.
Apriem Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $432K in Q1 2018.
194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Apriem Advisors's 13F filing for Q4 2018, filed 19 Feb 2019.